Virus-like particles (VLPs): A promising platform for combating against Newcastle disease virus.

Cargo delivery Delivery vehicles Expression systems Newcastle virus disease VLPs Vaccine

Journal

Vaccine: X
ISSN: 2590-1362
Titre abrégé: Vaccine X
Pays: England
ID NLM: 101748769

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 12 10 2023
revised: 11 12 2023
accepted: 13 01 2024
medline: 29 1 2024
pubmed: 29 1 2024
entrez: 29 1 2024
Statut: epublish

Résumé

The global poultry industry plays a pivotal role in providing eggs and meat for human consumption. However, outbreaks of viral disease, especially Newcastle virus disease (NDV), within poultry farms have detrimental effects on various zootechnical parameters, such as body weight gain, feed intake, feed conversion ratio, as well as the quality of egg and meat production. Cases of vaccine failure have been reported in regions where highly pathogenic strains of NDV are prevalent. To tackle this challenge, virus-like particles (VLPs) have emerged as a potential solution. VLPs closely resemble natural viruses, offering biocompatibility and immune-stimulating properties that make them highly promising for therapeutic applications against NDV. Hence, this review emphasizes the significance of NDV and the need for effective treatments. The manuscript will contain several key aspects, starting with an exploration of the structure and properties of NDV. Subsequently, the paper will delve into the characteristics and benefits of VLPs compared to conventional drug delivery systems. A comprehensive analysis of VLPs as potential vaccine candidates targeting NDV will be presented, along with a discussion on strategies for loading cargo into these NDV-targeting VLPs. The review will also examine various expression systems utilized in the production of NDV-targeting VLPs. Additionally, the manuscript will address future prospects and challenges in the field, concluding with recommendations for further research.

Identifiants

pubmed: 38283623
doi: 10.1016/j.jvacx.2024.100440
pii: S2590-1362(24)00013-5
pmc: PMC10811427
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

100440

Informations de copyright

© 2024 Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Ali niazi reports was provided by Shiraz University. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Mohammad Sadegh Taghizadeh (MS)

Institute of Biotechnology, Shiraz University, Shiraz, Iran.

Ali Niazi (A)

Institute of Biotechnology, Shiraz University, Shiraz, Iran.

Alireza Afsharifar (A)

Plant Virus Research Center, School of Agriculture, Shiraz University, Shiraz, Iran.

Classifications MeSH